Zhejiang Apeloa Biotechnology Co., Ltd – FDA 483, Sep 4, 2023
Zhejiang Apeloa Biotechnology Co., Ltd. in Dongyang, China, an animal drug API manufacturer, was cited for significant quality control issues during an FDA inspection. Observations included inadequate investigations into out-of-specification results and contamination, deficient laboratory OOS procedures that could permit retesting without scientific basis, and a water manufacturing system lacking proper validation and maintenance. These findings indicate a need for improved quality management and process control.
ID · e14b1179-310c-41b9-beec-5e2d7f64c32c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.